Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain

Cancer-associated Pain Clinical Trial

Official title:
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain

Status Completed

Clinical Trial Summary

The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain. Hypothesis: Treatment of pain with intrathecal (spinal) therapy is associated with little alteration of immune function as measured by biomarkers in the blood of cancer patients with moderate to severe pain.

Clinical Trial Description

Biomarkers of immune function will be measured before and after patients receive an intrathecal pain pump for management of cancer pain. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02151513
Study type	Observational
Source	University of Utah
Contact
Status	Completed
Phase
Start date	April 1, 2014
Completion date	June 1, 2018

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04809935` - EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy	Phase 4
	Recruiting	`NCT04875286` - Patient Reported Symptom Control With THC or CBD Use